NCT03587844 2026-04-03Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting58 enrolled
NCT06854653 2026-03-31A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLPrescient Therapeutics, Ltd.Phase 2 Recruiting115 enrolled